Patent: 7,612,041
✉ Email this page to a colleague
Summary for Patent: 7,612,041
| Title: | Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth |
| Abstract: | In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density. |
| Inventor(s): | John Knopf, Jasbir Seehra |
| Assignee: | Acceleron Pharma Inc |
| Application Number: | US11/603,485 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,612,041
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Llc | WINREVAIR | sotatercept-csrk | For Injection | 761363 | March 26, 2024 | ⤷ Start Trial | 2026-11-22 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,612,041
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200805408 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2007062188 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2008100384 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2009137075 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
